XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Total revenues $ 1,331,868 $ 1,156,282 $ 3,971,129 $ 3,427,639
Costs and expenses:        
Cost of services and product development 416,837 359,237 1,218,405 1,044,506
Selling, general and administrative 613,031 512,573 1,835,846 1,488,324
Depreciation 22,882 25,371 68,993 76,972
Amortization of intangibles 24,369 27,109 74,271 83,777
Acquisition and integration charges 1,331 1,771 5,827 3,713
Total costs and expenses 1,078,450 926,061 3,203,342 2,697,292
Operating income 253,418 230,221 767,787 730,347
Interest expense, net (30,286) (31,599) (91,399) (85,138)
Gain on event cancellation insurance claims 0 0 0 135,545
Other income, net 8,930 211 46,684 12,019
Income before income taxes 232,062 198,833 723,072 792,773
Provision for income taxes 58,517 49,968 172,087 208,572
Net income $ 173,545 $ 148,865 $ 550,985 $ 584,201
Net income per share:        
Basic (in dollars per share) $ 2.19 $ 1.78 $ 6.84 $ 6.80
Diluted (in dollars per share) $ 2.17 $ 1.76 $ 6.77 $ 6.72
Weighted average shares outstanding:        
Basic (in shares) 79,259 83,566 80,516 85,877
Diluted (in shares) 80,059 84,766 81,373 86,925
Research        
Revenues:        
Total revenues $ 1,147,823 $ 1,037,124 $ 3,426,532 $ 3,020,094
Conferences        
Revenues:        
Total revenues 77,031 24,415 200,910 107,396
Consulting        
Revenues:        
Total revenues $ 107,014 $ 94,743 $ 343,687 $ 300,149